Kurume, Japan

Hironori Koga

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Kurume University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hironori Koga. Retrieved from https://idiyas.com/inventor/hironori-koga

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hironori Koga: Innovator in Pancreatic Cancer Research

Introduction

Hironori Koga is a prominent inventor based in Kurume, Japan. He has made significant contributions to the field of medical research, particularly in the area of cancer biomarkers. His work is vital for advancing the understanding and treatment of pancreatic cancer.

Latest Patents

Hironori Koga holds a patent titled "Use of MicroRNA as Pancreatic Cancer Biomarker." This innovative patent highlights the potential of microRNA as a diagnostic tool for pancreatic cancer, which is known for its late diagnosis and poor prognosis. His research aims to improve early detection and treatment options for patients suffering from this devastating disease. He has 1 patent to his name.

Career Highlights

Koga is affiliated with Kurume University, where he conducts his research and collaborates with other experts in the field. His dedication to cancer research has positioned him as a key figure in the scientific community, contributing to the advancement of medical knowledge and patient care.

Collaborations

Throughout his career, Hironori Koga has worked alongside notable colleagues, including Takahiko Sakaue and Hideki Iwamoto. These collaborations have fostered a rich environment for innovation and discovery in cancer research.

Conclusion

Hironori Koga's work in pancreatic cancer research exemplifies the importance of innovation in medicine. His contributions through patents and collaborations continue to pave the way for advancements in cancer diagnostics and treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…